Overview

  • Product nameAnti-PGCA antibody
  • Description
    Rabbit polyclonal to PGCA
  • SpecificityThe selective antibodies were generated against conserved sequences near the N terminus and the C terminal end of the protein that are unique to PGCA protein. The PGCA antibody labels a 127 to 130 kDa protein in various tissues.
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide:

    CVRTYWLLGERGCSTRG

    , corresponding to C terminal amino acids 1042-1057 of Human PGCA.

  • Positive control
    • Brain, kidney and spleen.

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab14918 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/500. Detects a band of approximately 127 kDa.

Target

  • RelevanceCyclic GMP (cGMP) is a key messenger in several signal transduction pathways. The intracellular levels of cGMP are maintained by the activity of opposing enzymes: synthesizing gualylyl cyclases (GC) and hydrolyzing phosphodiesterases (PDEs). The synthesizing enzymes (GCs) are found in two forms: cytosolic (soluble) and membrane bound (particulate). In the last several years, new members of particulate guanylate cyclase family have been identified, and significant progress has been made in understanding the molecular mechanisms that underlie the regulation of this family of enzymes. In response to G protein coupled receptor stimulation, the cGMP can be produced from GTP by either cytoplasmic, soluble guanylate cyclase (sGC) that are heterodimers stimulated by nitric oxide and carbon monoxide, or by particulate membrane bound guanylyl cyclases which are activated in a complex mechanism by natriuretic peptides. Particulate GC (PGCs) have 7 different isoforms, PGC A through PGC G, and are expressed in most tissues in isoform specific manner. There is significant structural homology among various PGCs. There is a large N terminal extracellular domain (ECD), a single TMD, and a large intracellular domain with protein kinase activity (KLD), a C terminal catalytic domain (CD), and in between is a dimmerization domain (DD). Both PGC A and PGC B are posphorylated at Serine residues in the KLD. Non ionic detergents stimulated particulate guanylate cyclase activity in cerebral cortex of rat 8- to 12-fold, while stimulation of soluble enzyme was 1.3- to 2.5-fold. It has been shown that a significant number of hippcampal astrocytes (67%) contained both soluble and particulate guanylate cyclases in the same cell.
  • Cellular localizationType I membrane protein.
  • Alternative names
    • Particulate Guanylate Cyclase A antibody

Anti-PGCA antibody images

  • Anti-PGCA antibody (ab14918) at 1/500 dilution

References for Anti-PGCA antibody (ab14918)

ab14918 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab14918.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"